CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Metacrine, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Metacrine, Inc.
231 Market Place
Suite 373
Phone: (858) 281-4948p:858 281-4948 San Ramon, CA  94583  United States Fax: (858) 369-7825f:858 369-7825

This company ceased filing statements with the SEC on 3/24/2023.
This company is no longer actively traded on any major stock exchange.

Business Summary
Metacrine, Inc. is a United States-based biotechnology company. The Company is engaged in developing therapeutics for metabolic diseases. The Company leverages approximately two mechanistically distinct programs to target type 2 diabetes, NASH and other metabolic diseases and liver disorders. The Company focuses on advancing research in nuclear hormone receptors for treatment of metabolic diseases.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202212/31/2021YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Treasurer, Secretary DaveMaggio 64 3/24/2023 3/24/2023
Director H. MichaelHogan 60 3/23/2023 3/23/2023

General Information
Number of Employees: 10 (As of 9/30/2022)
Outstanding Shares: 43,832,832 (As of 2/3/2023)
Shareholders: 37
Stock Exchange: OTC
Federal Tax Id: 472297384
Fax Number: (858) 369-7825
Email Address: investors@metacrine.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 20, 2024